The Effect of the KLOP Wheel Application in Family Planning Decision Making in the Practice of Midwife a Banjarbaru
Keywords:
KLOP Wheel Application, Family Planning Decisions, Medical Eligibility CriteriaAbstract
The KLOP wheel in Indonesia, which stands for Circle Diagram and Application of Medical Feasibility in the Use of Contraception. The importance of the KLOP wheel as a screening tool before using contraception is because it can help decision making by taking into account the medical conditions or medical characteristics of the client. The use of KLOP aims to reduce medical barriers and increase access and quality of family planning services, because in clients with medical conditions or special characteristics, there are contraceptive methods that may worsen medical conditions or create health risks. Objective: To find out the effect of the KLOP Wheel application in family planning decision making in the practice of Midwife A Banjarbaru. Method: This research is quantitative research with an experimental design method (Quasi Experiment). The population is old family planning acceptors and new family planning acceptors, totaling 120 people and a sample of 30 people. Results: The most common type of birth control used before treatment was a combination injection, 9 people (30%). The most common type of birth control used after treatment was a combination injection, 13 people (46.6%). The relationship between the effect of the Roda KLOP application and family planning decision making was obtained by p-value (0.030). Conclusion: There is a relationship between the effect of the Roda KLOP application and family planning decision making, which is expected to facilitate family planning decision making according to medical conditions or medical characteristics. The ability and accuracy of officers in screening medical eligibility criteria is expected to improve the quality of contraceptive services.
Downloads
References
N. K. Dev, “Industry 4.0 and circular economy: Operational excellence for sustainable reverse supply chain performance,” Resour Conserv Recycl, vol. 153, 2020, doi: 10.1016/j.resconrec.2019.104583.
K. Alsop, “BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian ovarian cancer study group,” Journal of Clinical Oncology, vol. 30, no. 21, pp. 2654–2663, 2012, doi: 10.1200/JCO.2011.39.8545.
S. Kaasa, “Integration of oncology and palliative care: a Lancet Oncology Commission,” Lancet Oncol, vol. 19, no. 11, 2018, doi: 10.1016/S1470-2045(18)30415-7.
Y. Bombard, “Engaging patients to improve quality of care: A systematic review,” Implementation Science, vol. 13, no. 1, 2018, doi: 10.1186/s13012-018-0784-z.
S. R. Ommen, “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” J Am Coll Cardiol, vol. 76, no. 25, 2020, doi: 10.1016/j.jacc.2020.08.045.
R. E. Bernacki, “Communication about serious illness care goals: A review and synthesis of best practices,” JAMA Intern Med, vol. 174, no. 12, pp. 1994–2003, 2014, doi: 10.1001/jamainternmed.2014.5271.
A. F. Connors, “A controlled trial to improve care for seriously ill hospitalized patients: The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT),” J Am Med Assoc, vol. 274, no. 20, pp. 1591–1598, 1995, doi: 10.1001/jama.274.20.1591.
N. Salari, “The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis,” J Orthop Surg Res, vol. 16, no. 1, 2021, doi: 10.1186/s13018-021-02772-0.
C. Houghton, “Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: A rapid qualitative evidence synthesis,” Cochrane Database of Systematic Reviews, vol. 4, pp. 1–55, 2020, doi: 10.1002/14651858.CD013582.
C. Chapron, “Rethinking mechanisms, diagnosis and management of endometriosis,” Nat Rev Endocrinol, vol. 15, no. 11, pp. 666–682, 2019, doi: 10.1038/s41574-019-0245-z.
J. A. C. Rietjens, “Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care,” Lancet Oncol, vol. 18, no. 9, 2017, doi: 10.1016/S1470-2045(17)30582-X.
H. Wen, “Echinococcosis: Advances in the 21st century,” Clin Microbiol Rev, vol. 32, no. 2, 2019, doi: 10.1128/CMR.00075-18.
A. C. McKee, “Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury,” J Neuropathol Exp Neurol, vol. 68, no. 7, pp. 709–735, 2009, doi: 10.1097/NEN.0b013e3181a9d503.
I. Novak, “Early, accurate diagnosis and early intervention in cerebral palsy: Advances in diagnosis and treatment,” JAMA Pediatr, vol. 171, no. 9, pp. 897–907, 2017, doi: 10.1001/jamapediatrics.2017.1689.
A. Costello, “Managing the health effects of climate change. Lancet and University College London Institute for Global Health Commission,” The Lancet, vol. 373, no. 9676, pp. 1693–1733, 2009, doi: 10.1016/S0140-6736(09)60935-1.
S. L. Hyman, “Identification, evaluation, and management of children with autism spectrum disorder,” Pediatrics, vol. 145, no. 1, 2020, doi: 10.1542/PEDS.2019-3447.
S. Whitmee, “Safeguarding human health in the Anthropocene epoch: Report of the Rockefeller Foundation-Lancet Commission on planetary health,” The Lancet, vol. 386, no. 10007, pp. 1973–2028, 2015, doi: 10.1016/S0140-6736(15)60901-1.
H. Herrman, “Time for united action on depression: a Lancet–World Psychiatric Association Commission,” The Lancet, vol. 399, no. 10328, pp. 957–1022, 2022, doi: 10.1016/S0140-6736(21)02141-3.
E. K. Alexander, “2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum,” Thyroid, vol. 27, no. 3, pp. 315–389, 2017, doi: 10.1089/thy.2016.0457.
S. I. Hay, “Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016,” The Lancet, vol. 390, no. 10100, pp. 1260–1344, 2017, doi: 10.1016/S0140-6736(17)32130-X.
M. S. Adiputra, N. W. Trisnadewi, N. P. W. Oktaviani, S. A. Munthe, I. Budiastutik, A. Faridi, R. Ramdany, R. J. Fitriani, P. O. A. Tania, B. F. Rahmiati, S. A. Lusiana, A. Susilawaty, E. Sianturi, and Suryana, "Health Research Methodology," in Yayasan Kita Tulis, R. Watrianthos and J. Simarmata, Eds., 2021.
BKKBN, BKKBN Strategic Plan 2020-2024, 2020.
BKKBN, "Guidelines for Contraceptive and Family Planning Services," Angewandte Chemie International Edition, vol. 6, no. 11, pp. 951-952, 2021.
South Kalimantan Provincial Health Office, Health Profile of South Kalimantan Province Year, 2021.
Ministry of Health, Indonesia Health Profile 2018, Indonesian Ministry of Health, 2018.
Ministry of Health, Indonesia Health Profile 2020, Indonesian Ministry of Health, 2021.
P. D. Lijan and D. Sarton, Quantitative Research Methodology.pdf, Raja Grafindo Persada, 2021.
R. Matahari, F. P. Utami, and S. Sugiharti, "Textbook of Family Planning and Contraception," in Pustaka Ilmu, vol. 1, 2018.
Novianti, "The Relationship Between the Availability of Contraceptives and the Use of Contraceptives in Couples of Fertile Age," J. Kesehat. J. Ilm. Multi Sci., 2023.
Ministry of Health of the Republic of Indonesia, Indonesia Health Profile, 2021, 2021.
World Health Organization, "Contraception," WHO, 2019.
R. Zakaria, "Effectiveness of Using Who Wheel Criteria and Contraceptive Selection Decision Aids," vol. 2, no. 2, pp. 78-86, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Zoraya Defada Nawiswari, Novita Dewi Iswandari, Dede Mahdiyah, Elvine Ivana Kabuhung
This work is licensed under a Creative Commons Attribution 4.0 International License.
